These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6292987)

  • 1. The indole hallucinogens--a new look at their mechanisms of action.
    Psychopharmacol Bull; 1982 Jul; 18(3):168-83. PubMed ID: 6292987
    [No Abstract]   [Full Text] [Related]  

  • 2. Recognition and activation of a 5-HT receptor by hallucinogens and indole derivatives.
    Weinstein H; Osman R; Mercier G
    NIDA Res Monogr; 1988; 90():243-55. PubMed ID: 2855856
    [No Abstract]   [Full Text] [Related]  

  • 3. The mode of action of indolamine and other hallucinogens.
    Boarder MR
    Essays Neurochem Neuropharmacol; 1977; 2():21-48. PubMed ID: 361385
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of phencyclidine and related substances with various indole, phenethylamine, and other psychotomimetics.
    Domino EF
    Psychopharmacol Bull; 1986; 22(3):973-6. PubMed ID: 3797598
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin receptor involvement in an animal model of the acute effects of hallucinogens.
    Geyer MA; Krebs KM
    NIDA Res Monogr; 1994; 146():124-56. PubMed ID: 8742797
    [No Abstract]   [Full Text] [Related]  

  • 6. The stimulus effects of serotonergic hallucinogens in animals.
    Winter JC
    NIDA Res Monogr; 1994; 146():157-82. PubMed ID: 8742798
    [No Abstract]   [Full Text] [Related]  

  • 7. Hallucinogens and non-hallucinogenic analogues.
    Oyeno ET
    Proc West Pharmacol Soc; 1968; 11():60-1. PubMed ID: 5734488
    [No Abstract]   [Full Text] [Related]  

  • 8. An investigation on the central effects of harmine, harmaline and related beta-carbolines.
    Fuentes JA; Longo VG
    Neuropharmacology; 1971 Jan; 10(1):15-23. PubMed ID: 5569304
    [No Abstract]   [Full Text] [Related]  

  • 9. II. The effects of some hallucinogens on aggressiveness of mice and rats.
    Kostowski W; Rewerski W; Piechocki T
    Pharmacology; 1972; 7(4):259-63. PubMed ID: 4672886
    [No Abstract]   [Full Text] [Related]  

  • 10. Electroencephalographic and behavioral effects of harmaline in intact cats and in cats with chronic mesencephalic transection.
    Villablanca J; Riobó F
    Psychopharmacologia; 1970; 17(4):302-13. PubMed ID: 4331726
    [No Abstract]   [Full Text] [Related]  

  • 11. Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action.
    Marek GJ; Aghajanian GK
    Drug Alcohol Depend; 1998; 51(1-2):189-98. PubMed ID: 9716940
    [No Abstract]   [Full Text] [Related]  

  • 12. [Research on psiloybin, a psychotropic substance from Psilocybe mexicana].
    RUEMMELE W; GNIRSS F
    Schweiz Arch Neurol Neurochir Psychiatr; 1961; 87():365-85. PubMed ID: 13744546
    [No Abstract]   [Full Text] [Related]  

  • 13. Hallucinogenic drug action on the somatosensory system.
    Werner G
    Psychopharmacol Bull; 1975 Apr; 11(2):63. PubMed ID: 1135385
    [No Abstract]   [Full Text] [Related]  

  • 14. Are hallucinogens psychoheuristic?
    Szára S
    NIDA Res Monogr; 1994; 146():33-51. PubMed ID: 8742793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of certain hallucinogens on the electroencephalogram and conditioned behavior of the rabbit].
    Baran L; Longo VG
    Therapie; 1965; 20(3):591-604. PubMed ID: 5840874
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psilocybin, a new hallucinogen].
    ROUBICEK J; DRVOTA S
    Cesk Psychiatr; 1960 Feb; 56():44-55. PubMed ID: 14439519
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of psilocybin on the excitability of the nerve centers].
    CHAUCHARD P; MAZOUE H
    C R Seances Soc Biol Fil; 1961; 155():71-2. PubMed ID: 24545494
    [No Abstract]   [Full Text] [Related]  

  • 18. The comparative behavioral effects of N,N-dimethyltryptamine and N,N-diethyltryptamine in primate dyads.
    Heinze WJ; Schlemmer RF; Tyler CB; Davis JM
    Biol Psychiatry; 1983 Jul; 18(7):829-36. PubMed ID: 6577915
    [No Abstract]   [Full Text] [Related]  

  • 19. [Teonanacatl and psilocybin].
    CERLETTI A
    Dtsch Med Wochenschr; 1959 Dec; 84():2317-21. PubMed ID: 13808846
    [No Abstract]   [Full Text] [Related]  

  • 20. [The place of psilocybin among other psychotropic substances].
    RUEMMELE W
    Schweiz Arch Neurol Neurochir Psychiatr; 1959; 84():348-52. PubMed ID: 14440055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.